Sonnet Biotherapeutics Receives Shareholder Approval to Merge with Hyperliquid Strategies

By: theblockbeats.news|2025/12/02 14:45:54
Teilen
copy

BlockBeats News, December 2nd, According to market sources, Sonnet Biotherapeutics has received shareholder approval to merge with Hyperliquid Strategies.

Previously reported, Hyperliquid Strategies plans to raise up to $1 billion, intended to be used to purchase HYPE, etc.

Beliebte Coins

Neueste Krypto-Nachrichten

Mehr lesen